Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Halegoua-Demarzio, Dina

< Back

Profile

dlh004

Dina Halegoua-DeMarzio, MD

Contact Dr. Halegoua-DeMarzio

132 S. 10th Street
Suite 480, Main Building
Philadelphia, PA 19107

(215) 955-8900
(215) 503-2146 fax

Medical School

Temple University School of Medicine - 2007

Residency

Thomas Jefferson University Hospital
Chief Resident - Thomas Jefferson University Hospital

Fellowship

3-year ABIM combined Gastroenterology & Transplant Hepatology - Thomas Jefferson University Hospital

Board Certification

Internal Medicine

Hospital Appointment

Thomas Jefferson University Hospital

Publications

Most Recent Peer-Reviewed Publications

  1. Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
  2. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
  3. Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study
  4. Pre-Liver Transplant Muscle Loss Is a Risk Factor for Post-Liver Transplantation Left Ventricular Systolic Dysfunction
  5. Obstetricians’ and gynecologists’ knowledge, education, and practices regarding chronic hepatitis b in pregnancy
  6. Pilot study of the prevalence of binge eating disorder in non-alcoholic fatty liver disease patients
  7. Listing practices for morbidly obese patients at liver transplantation centers in the United States
  8. Primary pancreatic lymphoma presenting as acute pancreatitis
  9. Management of the Liver Transplant Recipient: Approach to Allograft Dysfunction
  10. Training the next generation of hepatologist: What will they need to know?
  11. Training directors have positive perceptions of a competency-based gastroenterology and transplant hepatology fellowship program
  12. Spiral Enteroscopy Utilizing Capsule Location Index for Achieving High Diagnostic and Therapeutic Yield
  13. Complementary and alternative medications in hepatitis C infection
  14. Then and now: The progress in hepatitis B treatment over the past 20 years
  15. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy
  16. Treatment of severe alcoholic hepatitis with corticosteroids and pentoxifylline
  17. Hepatotoxicity of cardiovascular and antidiabetic drugs
  18. Sleep disorders and the prevalence of asymptomatic nocturnal acid and non-acid reflux
  19. Limited Sampling Estimates of Epigallocatechin Gallate Exposures in Cirrhotic and Noncirrhotic Patients With Hepatitis C After Single Oral Doses of Green Tea Extract
  20. Drug-induced hepatotoxicity in humans